Skip to search formSkip to main contentSkip to account menu

BAL 8557

Known as: BAL-8557, BAL8557 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

isavuconazole

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Mutant Isolates of Aspergillus fumigatus
にば Invasive pulmonary aspergillosis (IPA) continues to rise in concert with increasing にぱ numbers of immune suppression… 
Highly Cited
2007
Highly Cited
2007
In Vitro Activities of Isavuconazole and Other Antifungal Agents against Candida Bloodstream Isolates
ABSTRACT Isavuconazole is the active component of the new azole antifungal agent BAL8557, which is entering phase III clinical… 
Highly Cited
2006
Highly Cited
2006
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus.
BACKGROUND BAL8557 (WSA) is the water-soluble prodrug of the triazole BAL4815 with in vitro anti-Aspergillus activity. We… 
2006
2006
BAL-4815/BAL-8557 : Antifungal agent
As the number of immunocompromised individuals increases, fungi such as Candida spp. and Aspergillus spp. frequently cause severe… 
Review
2006
Review
2006
Gateways to clinical trials.
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)